cp wire

CP Wire Articles

Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock

On the heels of the FDA lifting its clinical hold on lead product BPX-501, Bellicum announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All... read more

Mon, 04/16/18 - 07:49 pm
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

  • Factor XIa inhibitor moving into Phase 2 Trials for Secondary Stroke Prevention
  • Factor Xia was first noticed as a potential approach to thrombosis because people with little... read more
Mon, 04/16/18 - 07:28 pm
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
  • Median Duration of Severe Oral Mucositis (SOM) Reduced to Less Than One Day
  • No Unplanned Office Visits, Emergency Department Visits, and/or Hospital Admissions Due to OM in... read more
Mon, 04/16/18 - 01:44 pm
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease


New Data from CytoReason published in Gut outlines the role of a new technological platform approach that has revealed a new blood-based biomarker that is 94% accurate in pretreatment... read more

Mon, 04/16/18 - 01:29 pm
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

  • Showed that treatment with esketamine resulted in a statistically significant, clinically meaningful... read more

Mon, 04/16/18 - 01:18 pm

Pages